CrossrefInfokarte
Patients with Extensive-Stage Small Cell Lung Cancer Harboring Less Than 4 Metastatic Sites May Benefit from Immune Checkpoint Inhibitor Rechallenge by Reshaping Tumor Microenvironment
ImmunoTargets and Therapy · 2024-10 · Volume 13 · 571-583
DOI: 10.2147/itt.s483093 ↗Abstract
Kein Abstract verfügbar.
EUVIMED